| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Abstract
Summary
This report is an essential source for in-depth information and data relating
to the France Diabetes Care Devices devices market. It also offers detailed
and comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the Diabetes Care Devices in
France.
Scope
• The report provides diabetes care devices information broken down into
detailed categories and segments in France.
• Total revenues, products
sold, end users, and average pricing.
• Market shares of all the key
competitors.
• Key pipeline products that are set to shape the market,
broken down by sector.
• Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
• Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
• Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
•
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
• Customer, hospitals and physicians data.
Reasons to buy
• Gain a strong understanding of the diabetes care devices market in
France.
• Evaluate and compare the attractiveness of the market in the
country.
• Identify growth segments and opportunities in each industry
sector within the country.
• Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
• Analyze the competitiveness of the
market in the country and identify hotspots.
• Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
• Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
• Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
TABLE OF CONTENTS
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2
Introduction 12
2.1 What Is This Report About? 12
2.2 Definitions
12
3 Healthcare Sector Review 14
3.1 Healthcare Sector Review 14
3.2 Healthcare Expenditure 14
3.3 Healthcare Infrastructure 15
3.4
Healthcare Policy 18
4 Diabetes Care Devices in France 19
4.1 Diabetes
Care Devices Overall Revenues (2000-2012) 19
4.2 Diabetes Care Devices
Overall Volume (2000-2012) 25
4.3 Diabetes Care Devices Overall Company
Share (2006-2007) 28
5 Glucose Monitoring in France 29
5.1 Glucose
Monitoring Overall Revenues (2000-2012) 29
5.2 Glucose Monitoring Overall
Volume (2000-2012) 37
5.3 Glucose Monitoring Average Price (2000-2012)
43
5.4 Glucose Monitoring Distribution Share (2006-2007) 47
5.5
Glucose Monitoring Company Share (2006-2007) 48
6 Insulin Delivery in
France 49
6.1 Insulin Delivery Overall Revenues (2000-2012) 49
6.2
Insulin Delivery Overall Volume (2000-2012) 61
6.3 Insulin Delivery
Average Price (2000-2012) 70
6.4 Insulin Delivery Distribution Share
(2006-2007) 78
6.5 Insulin Delivery Company Share (2006-2007) 79
7 F.
Hoffmann-La Roche Ltd. Company Profile 80
7.1 Company Overview 80
7.2
Business Overview 80
7.3 Value Chain Analysis 85
7.4 SWOT Analysis
88
7.5 Financial and Operational Review 92
7.6 Locations And
Subsidiaries 94
7.7 Financial Deals Landscape 95
7.8 Recent
Developments 151
8 LifeScan, Inc. Company Profile 164
8.1 Company
Overview 164
8.2 Business Overview 164
8.3 Locations And Subsidiaries
166
8.4 Recent Developments 167
8.5 LifeScan, Inc. Pipeline Products
167
9 Abbott Laboratories Company Profile 170
9.1 Company Overview
170
9.2 Business Overview 170
9.3 Value Chain Analysis 175
9.4
SWOT Analysis 178
9.5 Financial and Operational Review 181
9.6
Locations and Subsidiaries 183
9.7 Financial Deals Landscape 184
9.8
Recent Developments 212
9.9 Abbott Laboratories Pipeline Products 223
10 Novo Nordisk A/S Company Profile 231
10.1 Company Overview 231
10.2
Business Overview 231
10.3 Locations and Subsidiaries 233
10.4 Recent
Developments 235
10.5 Novo Nordisk A/S Pipeline Products 242
11 Bayer
HealthCare AG Company Profile 245
11.1 Company Overview 245
11.2
Business Overview 245
11.3 Value Chain Analysis 251
11.4 SWOT Analysis
253
11.5 Locations and Subsidiaries 257
11.6 Financial Deals Landscape
258
11.7 Recent Developments 262
11.8 Bayer HealthCare AG Pipeline
Products 269
12 Regulation System 274
12.1 Medical Equipment Approval
Process 274
12.2 Post Market Surveillance (PMS) 288
13 Pricing and
Reimbursement 289
13.1 Pricing and Reimbursement Policies 289
14
Distribution Structure 290
15 Appendix 291
15.1 Global Markets Direct
Research Methodology 291
15.2 Coverage 292
15.3 Secondary Research
292
15.4 Primary Research 293
15.5 Models 293
15.6 Forecasts
294
15.7 Expert Panels 294
15.8 Currency Conversion 295
15.9
Contact Us 296
15.10 Disclaimer 296
1.1 List of
Tables
Table 1: Number of Doctors by Specialty in France, 2003-2007 25
Table 2: Number of Hospital Wards by Specialty in France, 2003-2007 26
Table 3: Diabetes Care Devices, France, Overall Revenues ($ mn), 2000-2012
28
Table 4: Diabetes Care Devices, France, Overall Revenues ($ mn),
Historic, 2000-2007 29
Table 5: Diabetes Care Devices, France, Overall
Revenues ($ mn), Forecast, 2007-2012 30
Table 6: Diabetes Care Devices,
France, Overall Revenues ($ mn), 2000-2012 31
Table 7: Diabetes Care
Devices, France, Overall Revenues ($ mn), Historic, 2000-2007 32
Table 8:
Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012
33
Table 9: Diabetes Care Devices, France, Overall Volume (Units),
2000-2012 34
Table 10: Diabetes Care Devices, France, Overall Volume
(Units), Historic, 2000-2007 35
Table 11: Diabetes Care Devices, France,
Overall Volume (Units), Forecast, 2007-2012 36
Table 12: Diabetes Care
Devices, France, Overall Company Share by Revenue ($ mn), 2006-2007 37
Table 13: Glucose Monitoring, France, Overall Revenues ($ mn), Historic,
2000-2007 38
Table 14: Glucose Monitoring, France, Overall Revenues ($
mn), Forecast, 2007-2012 39
Table 15: Glucose Monitoring, France, Revenue
by Segment ($ mn), Historic, 2000-2007 40
Table 16: Glucose Monitoring,
France, Revenue by Segment ($ mn), Forecast, 2007-2012 41
Table 17: Blood
Glucose Test Strips, France, Overall Revenues ($ mn), Historic, 2000-2007
42
Table 18: Blood Glucose Test Strips, France, Overall Revenues ($ mn),
Forecast, 2007-2012 43
Table 19: Blood Glucose Meters, France, Overall
Revenues ($ mn), Historic, 2000-2007 44
Table 20: Blood Glucose Meters,
France, Overall Revenues ($ mn), Forecast, 2007-2012 45
Table 21: Glucose
Monitoring, France, Overall Volume (Units), Historic, 2000-2007 46
Table
22: Glucose Monitoring, France, Overall Volume (Units), Forecast, 2007-2012
47
Table 23: Blood Glucose Test Strips, France, Overall Volume (Units),
Historic, 2000-2007 48
Table 24: Blood Glucose Test Strips, France,
Overall Volume (Units), Forecast, 2007-2012 49
Table 25: Blood Glucose
Meters, France, Overall Volume (Units), Historic, 2000-2007 50
Table 26:
Blood Glucose Meters, France, Overall Volume (Units), Forecast, 2007-2012
51
Table 27: Blood Glucose Meters, France, Average Price ($), Historic,
2000-2007 52
Table 28: Blood Glucose Meters, France, Average Price ($),
Forecast, 2007-2012 53
Table 29: Blood Glucose Test Strips, France,
Average Price ($), Historic, 2000-2007 54
Table 30: Blood Glucose Test
Strips, France, Average Price ($), Forecast, 2007-2012 55
Table 31:
Glucose Monitoring, France, Distribution Share by Revenue ($ mn), 2006-2007
56
Table 32: Glucose Monitoring, France, Company Share by Revenue ($ mn),
2006-2007 57
Table 33: Insulin Delivery, France, Overall Revenues ($ mn),
Historic, 2000-2007 58
Table 34: Insulin Delivery, France, Overall
Revenues ($ mn), Forecast, 2007-2012 59
Table 35: Insulin Delivery,
France, Revenue by Segment ($ mn), Historic, 2000-2007 60
Table 36:
Insulin Delivery, France, Revenue by Segment ($ mn), Forecast, 2007-2012
61
Table 37: Insulin Pens, France, Overall Revenues ($ mn), Historic,
2000-2007 62
Table 38: Insulin Pens, France, Overall Revenues ($ mn),
Forecast, 2007-2012 63
Table 39: Insulin Pumps, France, Overall Revenues
($ mn), Historic, 2000-2007 64
Table 40: Insulin Pumps, France, Overall
Revenues ($ mn), Forecast, 2007-2012 65
Table 41: Insulin Syringes,
France, Overall Revenues ($ mn), Historic, 2000-2007 66
Table 42: Insulin
Syringes, France, Overall Revenues ($ mn), Forecast, 2007-2012 67
Table
43: Insulin Jet Injectors, France, Overall Revenues ($ mn), Historic,
2000-2007 68
Table 44: Insulin Jet Injectors, France, Overall Revenues ($
mn), Forecast, 2007-2012 69
Table 45: Insulin Delivery, France, Overall
Volume (Units), Historic, 2000-2007 70
Table 46: Insulin Delivery, France,
Overall Volume (Units), Forecast, 2007-2012 70
Table 47: Insulin Syringes,
France, Overall Volume (Units), Historic, 2000-2007 71
Table 48: Insulin
Syringes, France, Overall Volume (Units), Forecast, 2007-2012 72
Table 49:
Insulin Pens, France, Overall Volume (Units), Historic, 2000-2007 73
Table
50: Insulin Pens, France, Overall Volume (Units), Forecast, 2007-2012 74
Table 51: Insulin Pumps, France, Overall Volume (Units), Historic, 2000-2007
75
Table 52: Insulin Pumps, France, Overall Volume (Units), Forecast,
2007-2012 76
Table 53: Insulin Jet Injectors, France, Overall Volume
(Units), Historic, 2000-2007 77
Table 54: Insulin Jet Injectors, France,
Overall Volume (Units), Forecast, 2007-2012 78
Table 55: Insulin Jet
Injectors, France, Average Price ($), Historic, 2000-2007 79
Table 56:
Insulin Jet Injectors, France, Average Price ($), Forecast, 2007-2012 80
Table 57: Insulin Pens, France, Average Price ($), Historic, 2000-2007 81
Table 58: Insulin Pens, France, Average Price ($), Forecast, 2007-2012 82
Table 59: Insulin Pumps, France, Average Price ($), Historic, 2000-2007 83
Table 60: Insulin Pumps, France, Average Price ($), Forecast, 2007-2012 84
Table 61: Insulin Syringes, France, Average Price ($), Historic, 2000-2007
85
Table 62: Insulin Syringes, France, Average Price ($), Forecast,
2007-2012 86
Table 63: Insulin Delivery, France, Distribution Share by
Revenue ($ mn), 2006-2007 87
Table 64: Insulin Delivery, France, Company
Share by Revenue ($ mn), 2006-2007 88
Table 65: F. Hoffmann-La Roche
Ltd., SWOT Analysis, 2006 97
Table 66: F. Hoffmann-La Roche Ltd.,
Financial Statements, CHF Million, 2002-2006 101
Table 67: F.
Hoffmann-La Roche Ltd., Financial Ratios, CHF Million, 2002-2006 102
Table
68: F. Hoffmann-La Roche Ltd., Other Locations 103
Table 69: F.
Hoffmann-La Roche Ltd., Other Locations(Contd..) 104
Table 70: F.
Hoffmann-La Roche Ltd., Subsidiaries 104
Table 71: LifeScan, Inc.,
Other Locations 175
Table 72: Abbott Laboratories, SWOT Analysis,
2006 187
Table 73: Abbott Laboratories, Financial Statements, USD
Thousand, 2002-2006 190
Table 74: Abbott Laboratories, Financial
Ratios, USD Thousand, 2002-2006 191
Table 75: Abbott Laboratories,
Other Locations 192
Table 76: Abbott Laboratories, Subsidiaries
193
Table 77: Novo Nordisk A/S, Other Locations 242
Table 78:
Novo Nordisk A/S, Subsidiaries 243
Table 79: Bayer HealthCare AG,
SWOT Analysis 262
Table 80: Bayer HealthCare AG, Other Locations
266
Table 81: Currency Conversion from USD to Local Currency at 2007
Constant Rate 304
1.2 List of Figures
Figure 1: Total
Healthcare Expenditure in France, 2000 -- 2006 24
Figure 2: Diabetes Care
Devices, France, Overall Revenues ($ mn), 2000-2012 28
Figure 3: Diabetes
Care Devices, France, Overall Revenues ($ mn), Historic, 2000-2007 29
Figure 4: Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast,
2007-2012 30
Figure 5: Diabetes Care Devices, France, Overall Revenues ($
mn), 2000-2012 31
Figure 6: Diabetes Care Devices, France, Overall
Revenues ($ mn), Historic, 2000-2007 32
Figure 7: Diabetes Care Devices,
France, Overall Revenues ($ mn), Forecast, 2007-2012 33
Figure 8: Diabetes
Care Devices, France, Overall Volume (Units), 2000-2012 34
Figure 9:
Diabetes Care Devices, France, Overall Volume (Units), Historic, 2000-2007
35
Figure 10: Diabetes Care Devices, France, Overall Volume (Units),
Forecast, 2007-2012 36
Figure 11: Diabetes Care Devices, France, Overall
Company Share (%), 2007 37
Figure 12: Glucose Monitoring, France, Overall
Revenues ($ mn), Historic, 2000-2007 38
Figure 13: Glucose Monitoring,
France, Overall Revenues ($ mn), Forecast, 2007-2012 39
Figure 14: Glucose
Monitoring, France, Revenue by Segment ($ mn), Historic, 2000-2007 40
Figure 15: Glucose Monitoring, France, Revenue by Segment ($ mn), Forecast,
2007-2012 41
Figure 16: Blood Glucose Test Strips, France, Overall
Revenues ($ mn), Historic, 2000-2007 42
Figure 17: Blood Glucose Test
Strips, France, Overall Revenues ($ mn), Forecast, 2007-2012 43
Figure 18:
Blood Glucose Meters, France, Overall Revenues ($ mn), Historic, 2000-2007
44
Figure 19: Blood Glucose Meters, France, Overall Revenues ($ mn),
Forecast, 2007-2012 45
Figure 20: Glucose Monitoring, France, Overall
Volume (Units), Historic, 2000-2007 46
Figure 21: Glucose Monitoring,
France, Overall Volume (Units), Forecast, 2007-2012 47
Figure 22: Blood
Glucose Test Strips, France, Overall Volume (Units), Historic, 2000-2007
48
Figure 23: Blood Glucose Test Strips, France, Overall Volume (Units),
Forecast, 2007-2012 49
Figure 24: Blood Glucose Meters, France, Overall
Volume (Units), Historic, 2000-2007 50
Figure 25: Blood Glucose Meters,
France, Overall Volume (Units), Forecast, 2007-2012 51
Figure 26: Blood
Glucose Meters, France, Average Price ($), Historic, 2000-2007 52
Figure
27: Blood Glucose Meters, France, Average Price ($), Forecast, 2007-2012
53
Figure 28: Blood Glucose Test Strips, France, Average Price ($),
Historic, 2000-2007 54
Figure 29: Blood Glucose Test Strips, France,
Average Price ($), Forecast, 2007-2012 55
Figure 30: Glucose Monitoring,
France, Distribution Share (%), 2007 56
Figure 31: Glucose Monitoring,
France, Company Share (%), 2007 57
Figure 32: Insulin Delivery, France,
Overall Revenues ($ mn), Historic, 2000-2007 58
Figure 33: Insulin
Delivery, France, Overall Revenues ($ mn), Forecast, 2007-2012 59
Figure
34: Insulin Delivery, France, Revenue by Segment ($ mn), Historic, 2000-2007
60
Figure 35: Insulin Delivery, France, Revenue by Segment ($ mn),
Forecast, 2007-2012 61
Figure 36: Insulin Pens, France, Overall Revenues
($ mn), Historic, 2000-2007 62
Figure 37: Insulin Pens, France, Overall
Revenues ($ mn), Forecast, 2007-2012 63
Figure 38: Insulin Pumps, France,
Overall Revenues ($ mn), Historic, 2000-2007 64
Figure 39: Insulin Pumps,
France, Overall Revenues ($ mn), Forecast, 2007-2012 65
Figure 40: Insulin
Syringes, France, Overall Revenues ($ mn), Historic, 2000-2007 66
Figure
41: Insulin Syringes, France, Overall Revenues ($ mn), Forecast, 2007-2012
67
Figure 42: Insulin Jet Injectors, France, Overall Revenues ($ mn),
Historic, 2000-2007 68
Figure 43: Insulin Jet Injectors, France, Overall
Revenues ($ mn), Forecast, 2007-2012 69
Figure 44: Insulin Syringes,
France, Overall Volume (Units), Historic, 2000-2007 71
Figure 45: Insulin
Syringes, France, Overall Volume (Units), Forecast, 2007-2012 72
Figure
46: Insulin Pens, France, Overall Volume (Units), Historic, 2000-2007 73
Figure 47: Insulin Pens, France, Overall Volume (Units), Forecast, 2007-2012
74
Figure 48: Insulin Pumps, France, Overall Volume (Units), Historic,
2000-2007 75
Figure 49: Insulin Pumps, France, Overall Volume (Units),
Forecast, 2007-2012 76
Figure 50: Insulin Jet Injectors, France, Overall
Volume (Units), Historic, 2000-2007 77
Figure 51: Insulin Jet Injectors,
France, Overall Volume (Units), Forecast, 2007-2012 78
Figure 52: Insulin
Jet Injectors, France, Average Price ($), Historic, 2000-2007 79
Figure
53: Insulin Jet Injectors, France, Average Price ($), Forecast, 2007-2012
80
Figure 54: Insulin Pens, France, Average Price ($), Historic, 2000-2007
81
Figure 55: Insulin Pens, France, Average Price ($), Forecast, 2007-2012
82
Figure 56: Insulin Pumps, France, Average Price ($), Historic,
2000-2007 83
Figure 57: Insulin Pumps, France, Average Price ($),
Forecast, 2007-2012 84
Figure 58: Insulin Syringes, France, Average Price
($), Historic, 2000-2007 85
Figure 59: Insulin Syringes, France, Average
Price ($), Forecast, 2007-2012 86
Figure 60: Insulin Delivery, France,
Distribution Share (%), 2007 87
Figure 61: Insulin Delivery, France,
Company Share (%), 2007 88
Figure 62: F. Hoffmann-La Roche Ltd.,
Value Chain Analysis 94
Figure 63: Abbott Laboratories, Value Chain
Analysis 184
Figure 64: Bayer HealthCare AG, Value Chain Analysis
260
Figure 65: Flowchart for Classification of Non-invasive Devices in
France, 2007 285
Figure 66: Flowchart for Classification of Invasive
Devices in France, 2007 286
Figure 67: Flowchart for Classification of
Invasive Devices in France, 2007 287
Figure 68: Flowchart for
Classification of Invasive Devices in France, 2007 288
Figure 69:
Flowchart for Classification of Invasive Devices in France, 2007 289
Figure 70: Flowchart for Classification of Active Devices in France, 2007
290
Figure 71: Flowchart for Classification of Active Devices in France,
2007 291
Figure 72: Flowchart for Classification of Devices except
Non-invasive, Invasive and Active Devices in France, 2007 292
Figure 73:
Conformity Assessment of Class-I Medical Devices in France, 2007 293
Figure 74: Conformity Assessment of Class-IIa Medical Devices in France, 2007
294
Figure 75: Conformity Assessment of Class-IIb Medical Devices in
France, 2007 295
Figure 76: Conformity Assessment of Class-III Medical
Devices in France, 2007 296
Figure 77: Medical Equipment Distribution
Structure in France, 2007 299
Figure 78: Global Markets Direct Methodology
300
|
